Premier Value Arthritis Pain Reliever
NDC Package 68016-333-01
Package Information
Premier Value Arthritis Pain Reliever is do not take more than directed (see overdose warning)adultstake 2 caplets every 8 hours with waterswallow whole; do not crush, chew, split or dissolvedo not take more than 6 caplets in 24 hoursdo not use for more than 10 days unless directed by a doctorunder 18 years of ageask a doctor. Marketed by Chain Drug Consortium, Llc., this product is identified by NDC 68016-333 and is authorized under FDA application ANDA076200.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 68016 - Chain Drug Consortium, Llc.
- 68016-333 - Premier Value Arthritis Pain Reliever
- 68016-333-01 - 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE
- 68016-333 - Premier Value Arthritis Pain Reliever
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (68016-333). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 68016-333-01 identifies a specific commercial package of 100 tablet, film coated, extended release in 1 bottle of Premier Value Arthritis Pain Reliever, labeled by Chain Drug Consortium, Llc.. This product is billed for "EA" each discreet unit and contains an estimated amount of 100 billable units per package. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Chain Drug Consortium, Llc. on April 30, 2002. The current certification is valid through December 31, 2025.
How is this Chain Drug Consortium, Llc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 68016033301. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 100 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.